These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17655171)

  • 1. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide.
    Golec M
    Ann Agric Environ Med; 2007; 14(1):1-4. PubMed ID: 17655171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of salivary histatin and the human cathelicidin LL-37 in wound healing and innate immunity.
    Oudhoff MJ; Blaauboer ME; Nazmi K; Scheres N; Bolscher JG; Veerman EC
    Biol Chem; 2010 May; 391(5):541-8. PubMed ID: 20302519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
    Shaykhiev R; Beisswenger C; Kändler K; Senske J; Püchner A; Damm T; Behr J; Bals R
    Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L842-8. PubMed ID: 15964896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
    Fahy RJ; Wewers MD
    Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
    Tjabringa GS; Rabe KF; Hiemstra PS
    Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease.
    Jiang YY; Xiao W; Zhu MX; Yang ZH; Pan XJ; Zhang Y; Sun CC; Xing Y
    Respir Med; 2012 Dec; 106(12):1680-9. PubMed ID: 22981321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Scoping Analysis of Cathelicidin in Response to Organic Dust Exposure and Related Chronic Lung Illnesses.
    Golec M; Lemieszek MK; Dutkiewicz J; Milanowski J; Barteit S
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.
    Koziel J; Bryzek D; Sroka A; Maresz K; Glowczyk I; Bielecka E; Kantyka T; Pyrć K; Svoboda P; Pohl J; Potempa J
    J Immunol; 2014 Jun; 192(11):5363-72. PubMed ID: 24771854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS.
    Shaykhiev R; Sierigk J; Herr C; Krasteva G; Kummer W; Bals R
    FASEB J; 2010 Dec; 24(12):4756-66. PubMed ID: 20696857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism.
    Hu Z; Murakami T; Suzuki K; Tamura H; Kuwahara-Arai K; Iba T; Nagaoka I
    PLoS One; 2014; 9(1):e85765. PubMed ID: 24454930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro.
    Ciornei CD; Egesten A; Bodelsson M
    Acta Anaesthesiol Scand; 2003 Feb; 47(2):213-20. PubMed ID: 12631052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model.
    Nagaoka I; Tamura H; Reich J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
    Nan YH; Bang JK; Jacob B; Park IS; Shin SY
    Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation.
    Suzuki K; Murakami T; Hu Z; Tamura H; Kuwahara-Arai K; Iba T; Nagaoka I
    J Immunol; 2016 Feb; 196(3):1338-47. PubMed ID: 26729811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface.
    Huang LC; Petkova TD; Reins RY; Proske RJ; McDermott AM
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2369-80. PubMed ID: 16723446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the multifunctional peptide LL-37 in host defense.
    Kai-Larsen Y; Agerberth B
    Front Biosci; 2008 May; 13():3760-7. PubMed ID: 18508470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
    Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
    Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD patients and healthy individuals.
    Golec M; Reichel C; Lemieszek M; Mackiewicz B; Buczkowski J; Sitkowska J; Skòrska C; Dutkiewicz J; Milanowski J; Ziesche R
    J Biol Regul Homeost Agents; 2012; 26(4):617-25. PubMed ID: 23241112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary disease.
    Zhang Y; Jiang Y; Sun C; Wang Q; Yang Z; Pan X; Zhu M; Xiao W
    Biochem Biophys Res Commun; 2014 Jan; 443(1):103-9. PubMed ID: 24291709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.